Literature DB >> 6122478

A comparison of the cardiovascular and sedative actions of the alpha-adrenoceptor agonists, FLA-136 and clonidine, in the rat.

T C Hamilton, S D Longman.   

Abstract

1 The cardiovascular and sedative effects of FLA-136 have been compared with those of clonidine after intracerebroventricular (i.c.v.) administration in the rat. The effects of both drugs on pre- and postsynaptic alpha-adrenoceptors in the periphery have been investigated after intravenous (i.v.) administration in the pithed rat.2 In the anaesthetized rat, i.c.v. FLA-136 and clonidine produced dose-related hypotension, FLA-136 having three to 30 times less activity than clonidine; both drugs caused concomitant bradycardia. In the conscious rat i.c.v. FLA-136 had less sedative potential than clonidine, in terms of overt sedation assessed visually.3 Yohimbine reduced the hypotension and bradycardia produced by i.c.v. FLA-136 and clonidine; prazosin and mianserin also antagonized the cardiovascular responses to clonidine, but not those to FLA-136.4 Chemical sympathectomy by 6-hydroxydopamine (6-OHDA) markedly reduced the cardiovascular effects of FLA-136 but only slightly reduced those of clonidine.5 Naloxone antagonized the cardiovascular responses to clonidine, but not FLA-136, suggesting a direct or indirect involvement of central opiate receptors in the responses induced by clonidine.6 Metiamide attenuated the cardiovascular responses to FLA-136 and clonidine, implying a direct or indirect involvement of central histamine (H(2))-receptors in such responses.7 FLA-136, unlike clonidine, did not stimulate peripheral pre- or postsynaptic alpha-adrenoceptors in the pithed rat.8 FLA-136 is a novel centrally-acting hypotensive compound which, unlike clonidine, selectively stimulates central alpha-autoreceptors (yohimbine-sensitive) in the rat; these autoreceptors may be different from peripheral pre- and postsynaptic alpha-adrenoceptors. The results suggest that clonidine lowers blood pressure by stimulation of two types of central postsynaptic alpha-adrenoceptors in the rat, one type being sensitive to yohimbine and the other to prazosin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6122478      PMCID: PMC2071469          DOI: 10.1111/j.1476-5381.1982.tb08753.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  The preparation and antihypertensive activity of 4-amino-3-(2,6-dichlorobenzylidenehydrazino)-1,2,4-triazole and some related compounds.

Authors:  H E Eriksson; L G Florvall
Journal:  Acta Pharm Suec       Date:  1976

2.  Relative pre- and postsynaptic potencies of alpha-adrenoceptor agonists in the rabbit pulmonary artery.

Authors:  K Starke; T Endo; H D Taube
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

3.  A method of stimulating the complete sympathetic outflow from the spinal cord to blood vessels in the pithed rat.

Authors:  J S Gillespie; T C Muir
Journal:  Br J Pharmacol Chemother       Date:  1967-05

4.  Central adrenergic neurones and the initiation and development of experimental hypertension.

Authors:  G Haeusler; L Finch; H Thoenen
Journal:  Experientia       Date:  1972-10-15

Review 5.  The central action of antihypertensive drugs, mediated via central alpha-receptors.

Authors:  P A van Zwieten
Journal:  J Pharm Pharmacol       Date:  1973-02       Impact factor: 3.765

6.  Hypothermic effect of alpha-sympathomimetic agents and their antagonism by adrenergic and cholinergic blocking drugs.

Authors:  D Tsoucaris-Kupfer; H Schmitt
Journal:  Neuropharmacology       Date:  1972-09       Impact factor: 5.250

7.  Evidence for a central alpha-sympathomimetic action of clonidine in the rat.

Authors:  L Finch; R E Buckingham; R A Moore; T J Bucher
Journal:  J Pharm Pharmacol       Date:  1975-03       Impact factor: 3.765

8.  [Pharmacological effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, a new, antihypertensive substance].

Authors:  W Hoefke; W Kobinger
Journal:  Arzneimittelforschung       Date:  1966-08

9.  Construction and implantation of a permanent cannula for making injections into the lateral ventricle of the rat brain.

Authors:  J F Hayden; L R Johnson; R P Maickel
Journal:  Life Sci       Date:  1966-08       Impact factor: 5.037

10.  Sleep produced by clonidine (2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride).

Authors:  R B Holman; E E Shillito; M Vogt
Journal:  Br J Pharmacol       Date:  1971-12       Impact factor: 8.739

View more
  6 in total

1.  Opiate receptors and the endorphin-mediated cardiovascular effects of clonidine in rats: evidence for hypertension-induced mu-subtype to delta-subtype changes.

Authors:  R Mosqueda-Garcia; G Kunos
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  Protective action of clonidine against the arrhythmogenic and lethal effects of ouabain in guinea-pigs.

Authors:  G P Thomas; P M Stephen
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

3.  Prazosin partly blocks clonidine-induced hypotension in patients with essential hypertension.

Authors:  J Kapocsi; C Farsang; E S Vizi
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

4.  Cardiovascular effects of alpha-adrenergic drugs: differences between clonidine and guanabenz.

Authors:  J S Gutkind; M Kazanietz; M A Enero
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-04       Impact factor: 3.000

5.  Interaction between clonidine and physostigmine in normal rats and in rats after sinoaortic denervation.

Authors:  C A Taira; M A Enero
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-05       Impact factor: 3.000

6.  Treatment with clorgyline and pargyline differentially decreases clonidine-induced hypotension and bradycardia.

Authors:  J S Gutkind; M A Enero
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.